CDXC

ChromaDex Stock Price

6.68
0.36 (5.7%)
Upgrade to Real-Time
Regular Market
6.68

Low
3.82

52 Week Range

High
23.66

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
ChromaDex Corporation CDXC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.36 5.7% 6.68 13:16:31
Open Price Low Price High Price Close Price Prev Close
6.312 6.15 6.68 6.32
Bid Price Ask Price Spread News
6.68 6.70 0.02 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,604 317,150 $ 6.48 $ 2,053,658 - 3.82 - 23.66
Last Trade Time Type Quantity Stock Price Currency
13:18:26 1 $ 6.69 USD

Period:

Draw Mode:

ChromaDex Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 455.55M 68.20M 64.38M $ 59.26M $ -22.33M -0.33 -18.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 120.00k 25.30%

more financials information »

ChromaDex News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CDXC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.807.895.156.681,443,366-1.12-14.36%
1 Month7.818.755.157.19583,750-1.13-14.47%
3 Months9.0410.785.158.46509,804-2.36-26.11%
6 Months12.8812.975.158.88696,443-6.20-48.14%
1 Year4.5323.663.8212.751,296,3402.1547.46%
3 Years3.8523.662.5010.19616,7662.8373.51%
5 Years3.4123.662.2518.74492,1553.2795.89%

ChromaDex Description

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors.


Your Recent History
NASDAQ
CDXC
ChromaDex
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.